Richard E. Baxter - Acellular Dermal Matrices in Breast Surgery, an Issue of Clinics in Plastic Surgery

Clinics in Plastic Surgery, Vol. 39, No. 2, April 2012

ISSN: 0094-1298

doi: 10.1016/S0094-1298(12)00016-8

Contributors List

Clinics in Plastic Surgery

Acellular Dermal Matrices in Breast Surgery

Richard A. Baxter MD

Plastic Surgery Clinic, 6100 219th Street SW, Suite 290, Mountlake Terrace, WA 98043, USA

ISSN 0094-1298

Volume 39 Number 2 April 2012

Contents

Clinics in Plastic Surgery, Vol. 39, No. 2, April 2012

ISSN: 0094-1298

doi: 10.1016/S0094-1298(12)00018-1

Forthcoming Issues

Clinics in Plastic Surgery, Vol. 39, No. 2, April 2012

ISSN: 0094-1298

doi: 10.1016/j.cps.2012.02.008

Current State of the Art for Acellular Dermal Matrices in Breast Surgery

Richard A. Baxter, MD

Plastic Surgery Clinic, 6100 219th Street SW, Suite 290, Mountlake Terrace, WA 98043, USA

E-mail address: drbaxter@drbaxter.com

Richard A. Baxter, MD, Guest Editor

The use of acellular dermal matrices (ADMs) in breast surgery has been transformative over the past decade. For implant-related problems, they can provide a unifying solution to the multiple issues stemming from inadequate tissue for coverage and support. The concept of a living internal bra is a compelling one for patients and plastic surgeons alike. Challenging problems such as implant rippling, malposition, and capsular contracture have all found a potential solution with ADMs. Extending this concept to reconstruction, ADMs have helped define a new model. Along with increasing use of skin- and nipple-sparing mastectomy, the availability of BRCA genetic testing, and better implants, many patients now achieve superior outcomes with mastectomy than with breast-conserving treatment with radiation and lumpectomy. Many thoughtful innovators have contributed to these developments, and this issue of the Clinics in Plastic Surgery is dedicated to those forward-thinking surgeons.

Controversies remain and so I have encouraged the contributors to this issue to take a balanced view. Indications for use are not rigorously defined for every potential application despite the utility demonstrated by broad clinical experience, and prospective trial data where they exist often lack clearly delineated inclusion/exclusion criteria. This issue addresses the current state of the art with ADMs in breast surgery and I hope will provide some guidance as the science evolves.

Clinics in Plastic Surgery, Vol. 39, No. 2, April 2012

ISSN: 0094-1298

doi: 10.1016/j.cps.2011.09.007

Erratum

Skin Tissue EngineeringIn Vivo and In Vitro Applications CPS Volume 39, Issue 1, Pages 1-102 (January 2012)

Florian Groeber a,b,1, Monika Holeiterac,1, Martina Hampela,b, Svenja Hinderera,c, Katja Schenke-Laylanda,c,*

a Department of Cell and Tissue Engineering, Fraunhofer-Institute for Interfacial Engineering and Biotechnology (IGB), Nobelstrasse 12, 70569 Stuttgart, Germany

b Institute for Interfacial Engineering, Nobelstrasse 12, 70569 Stuttgart, Germany

c Faculty of Medicine, Eberhard Karls University Tbingen, Silcherstrasse 7, 72076 Tbingen, Germany

1 Both authors contributed equally to this manuscript.

* Corresponding author. Department of Cell and Tissue Engineering, Fraunhofer IGB, Nobelstrasse 12, 70569 Stuttgart, Germany.

This article is a re-publication of an article previously published in Advanced Drug Delivery Reviews, Volume 63, Issues 45, Pages 193-404 (30 April 2011); doi:10.1016/j.addr.2011.01.005.

This re-publication was initiated by the Publisher and credited to the original journal.

The article has been withdrawn due to the accidental and unintentional assignation of a new DOI.

The Publisher regrets the inconvenience caused.

Clinics in Plastic Surgery, Vol. 39, No. 2, April 2012

ISSN: 0094-1298

doi: 10.1016/j.cps.2011.12.001

Acellular Dermal Matrices in Breast Implant Surgery: Defining the Problem and Proof of Concept